Mangalam Drugs And Organics Prabhakar Zavar as an appointed
Mangalam Drugs And Organics (BSE: MANGALAM) said Prabhakar Zavar as an has been appointed. The company is valued at about ₹46.23 crore.
What happened
Mangalam Drugs And Organics (BSE: MANGALAM) informed the stock exchanges on 2 November 2026 at 04:10 PM that Prabhakar Zavar as an has been appointed.
Company snapshot
Mangalam Drugs And Organics is a micro-cap company, with a market value of about ₹46.23 crore.
The stock last traded at ₹29.21, against a 52-week range of ₹22.8–₹67.19 (56.5% below the high).
Before this filing the shares had moved −8.9% over the month and +5.5% over three months. Average daily turnover over the last 20 sessions was about ₹0.1 crore.
Promoters held 35.65% at the end of Q1 FY27. Foreign institutions owned 0.11% and domestic institutions 0.00%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 57 | -13.8 | -8.72 |
| Q2 FY26 | 107 | -21.1 | -13.36 |
| Q3 FY26 | 58 | -9.8 | -6.21 |
| Q4 FY26 | 67 | -13.4 | -8.48 |
| Q1 FY27 | 57 | -7.6 | -4.83 |
What history shows
BCEIE's records show 4 previous management change filings from the company since May 2026.
After those filings, the stock fell 0.3% on average the next trading day and was down 0.3% on average after five days (3 filings with price data).
Market-wide, 4,084 management change filings with an impact score of 50 or more saw an average next-day move of −0.1%, with 44% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 15 Sept 2026 | Appointment of Mr. Prabhakar Raghunath Zavar (DIN: 11940187) as Non-… | −4.7% | −3.6% |
| 12 Aug 2026 | Change in Auditors of the company. | +2.9% | −1.2% |
| 6 Aug 2026 | Intimation Of Resignation Tendered By Ragini Chokshi & Co.,… | +1.0% | +3.9% |
What to watch
- The appointment of a successor and any change in strategy or guidance.
- 5 November 2026: Board meeting — Financial Results/Other business matters.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.